Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 7Lymphoma, B-Cell, Marginal Zone 4Barrett Esophagus 4Lymphoma, Large B-Cell, Diffuse 3Breast Neoplasms 3Zollinger-Ellison Syndrome 2Squamous Cell Carcinoma of Head and Neck 2Lymphoma 2Inflammation 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Ulcer 1Solid Tumours 1Solid Tumor 1Prostate Cancer Patients 1Precancerous Gastric Lesions 1Pharmacokinetics of MDV3100 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Mouth Neoplasms 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hyperuricemia 1Healthy Adult Participants 1Gout 1Gastrinoma 1

Interventions

Exercise 5Vitamin D 2Tea 2Sufentanil 2Spironolactone 2Probiotics 2Oxycodone 2Omeprazole 2Morphine 2Metformin 2Etanercept 2Colchicine 2Ascorbic Acid 2ziprasidone 1soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1falcarinol 1falcarindiol 1epigallocatechin gallate 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Sulindac 1Sodium Salicylate 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Inflammation × Omeprazole × Clear all
NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed
196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

NCT01093755 2016-03-17

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Mayo Clinic

Phase 4 Completed
30 enrolled 12 charts
Gastrointestinal

Barrett Esophagus, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡